Kevin Yang

2.0k total citations
27 papers, 502 citations indexed

About

Kevin Yang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Kevin Yang has authored 27 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Kevin Yang's work include Melanoma and MAPK Pathways (4 papers), Autophagy in Disease and Therapy (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Kevin Yang is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Autophagy in Disease and Therapy (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Kevin Yang collaborates with scholars based in United States, Canada and Sweden. Kevin Yang's co-authors include Sharon M. Gorski, Cally J. Ho, Mark H. Norman, Longbin Liu, Daniel D. Kirchoff, Fadi F. Attiyeh, Jamie A. Schwartz, Barbara Wexelman, David Y. Lee and Jing Xu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Kevin Yang

23 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Yang United States 14 229 141 95 87 47 27 502
Kamlesh Yadav India 11 460 2.0× 58 0.4× 93 1.0× 42 0.5× 10 0.2× 24 568
Lenka Goldman United States 13 325 1.4× 60 0.4× 88 0.9× 42 0.5× 29 0.6× 22 571
Danny Hsu United States 12 214 0.9× 184 1.3× 117 1.2× 50 0.6× 28 0.6× 27 510
Fay Habens United Kingdom 9 299 1.3× 79 0.6× 106 1.1× 27 0.3× 10 0.2× 11 477
Yunting Luo United States 17 519 2.3× 148 1.0× 282 3.0× 15 0.2× 14 0.3× 27 814
Junhua Fan China 12 241 1.1× 127 0.9× 53 0.6× 36 0.4× 38 0.8× 27 469
Krishna Vaddi United States 13 212 0.9× 137 1.0× 188 2.0× 66 0.8× 40 0.9× 20 656
Ana Krivokuća Serbia 15 188 0.8× 92 0.7× 179 1.9× 24 0.3× 37 0.8× 46 559
Kokichi Suzuki Japan 10 144 0.6× 115 0.8× 86 0.9× 30 0.3× 24 0.5× 15 399

Countries citing papers authored by Kevin Yang

Since Specialization
Citations

This map shows the geographic impact of Kevin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Yang more than expected).

Fields of papers citing papers by Kevin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Yang. The network helps show where Kevin Yang may publish in the future.

Co-authorship network of co-authors of Kevin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Yang. A scholar is included among the top collaborators of Kevin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Yang. Kevin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Himsworth, Chelsea G., Agatha N. Jassem, Kevin Yang, et al.. (2025). Highly Pathogenic Avian Influenza A(H5N1) in Wild Birds and a Human, British Columbia, Canada, 2024. Emerging infectious diseases. 31(6). 1216–1221.
2.
Yang, Kevin & Karim Saleh. (2024). Dermoscopic Features of Cutaneous Endometriosis Arising in a Cesarean Scar: A Case Report. Case Reports in Dermatological Medicine. 2024(1). 6880602–6880602. 1 indexed citations
3.
Yang, Kevin, et al.. (2024). Imatinib-induced hyperpigmentation. JAAD Case Reports. 52. 28–30.
4.
Yang, Kevin, et al.. (2023). Dermatologic toxicities of anti-neoplastic immunotherapy in United States hospitalizations. Archives of Dermatological Research. 315(8). 2347–2350.
5.
Yang, Kevin & Sharon M. Gorski. (2022). Protocol for analysis of RNA-sequencing and proteome profiling data for subgroup identification and comparison. STAR Protocols. 3(2). 101283–101283. 4 indexed citations
6.
Yang, Kevin, C. Pan, Bina Kassamali, et al.. (2022). Sun-protective behaviors and skin cancer risk factors among American Indians and Alaskan Natives in the United States. Journal of the American Academy of Dermatology. 88(2). 488–490. 2 indexed citations
7.
Yang, Kevin & Vinod E. Nambudiri. (2021). Anticipating Ambulatory Automation: Potential Applications of Administrative and Clinical Automation in Outpatient Healthcare Delivery. Applied Clinical Informatics. 12(5). 1157–1160.
8.
Hu, Liping, Chunying Zhang, Kevin Yang, Meng Li, & Anisa Shaker. (2020). Human esophageal myofibroblasts increase squamous epithelial thickness via paracrine mechanisms in an in vitro model of gastroesophageal reflux disease. PLoS ONE. 15(9). e0238852–e0238852. 4 indexed citations
9.
Ho, Cally J., Katharina Rothe, Jing Xu, et al.. (2020). Puncta intended: connecting the dots between autophagy and cell stress networks. Autophagy. 17(4). 1028–1033. 6 indexed citations
10.
Yang, Kevin & Meera Mahalingam. (2020). Differing biologic behaviors of desmoplastic melanoma subtypes: Insights based on histopathologic, immunohistochemical, and genetic analyses. Journal of the American Academy of Dermatology. 83(2). 523–531. 6 indexed citations
11.
Yang, Kevin, Thor D. Stein, Bertrand R. Huber, et al.. (2020). Glioblastoma and malignant melanoma: Serendipitous or anticipated association?. Neuropathology. 41(1). 65–71. 3 indexed citations
12.
Williamson, Laura, Jasleen Grewal, Eric Y. Stutheit-Zhao, et al.. (2019). Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor. Molecular Case Studies. 5(3). a003814–a003814. 18 indexed citations
13.
Zhang, Chunying, Chao Niu, Kevin Yang, & Anisa Shaker. (2018). Human esophageal myofibroblast secretion of bone morphogenetic proteins and GREMLIN1 and paracrine regulation of squamous epithelial growth. Scientific Reports. 8(1). 12354–12354. 9 indexed citations
14.
Rothe, Katharina, Kevin Yang, Jing Xu, et al.. (2018). Diverse mechanisms of autophagy dysregulation and their therapeutic implications: does the shoe fit?. Autophagy. 15(2). 368–371. 6 indexed citations
15.
Liu, Longbin, Matthew R. Lee, Joseph L. Kim, et al.. (2016). Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling. Bioorganic & Medicinal Chemistry. 24(10). 2215–2234. 13 indexed citations
16.
Chittaranjan, Suganthi, Susanna Chan, C. Paul Yang, et al.. (2014). Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity. Oncotarget. 5(17). 7960–7979. 28 indexed citations
17.
Lee, David Y., Jamie A. Schwartz, Barbara Wexelman, et al.. (2013). Outcomes of pancreaticoduodenectomy for pancreatic malignancy in octogenarians: an American College of Surgeons National Surgical Quality Improvement Program analysis. The American Journal of Surgery. 207(4). 540–548. 46 indexed citations
18.
Wurz, Ryan P., Longbin Liu, Kevin Yang, et al.. (2012). Synthesis and structure–activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold. Bioorganic & Medicinal Chemistry Letters. 22(17). 5714–5720. 23 indexed citations
19.
Liu, Longbin, Mark H. Norman, Matthew Lee, et al.. (2012). Structure-Based Design of Novel Class II c-Met Inhibitors: 2. SAR and Kinase Selectivity Profiles of the Pyrazolone Series. Journal of Medicinal Chemistry. 55(5). 1868–1897. 65 indexed citations
20.
Frisse, Mark E., et al.. (2008). A regional health information exchange: architecture and implementation.. PubMed. 212–6. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026